ANI Pharmaceuticals, Inc. (ANIP)
74.24
-1.12
(-1.48%)
USD |
NASDAQ |
Aug 24, 16:00
74.24
0.00 (0.00%)
After-Hours: 19:57
ANI Pharmaceuticals Shareholders Equity (Quarterly) : 597.21M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 597.21M |
| March 31, 2026 | 562.30M |
| December 31, 2025 | 540.72M |
| September 30, 2025 | 505.82M |
| June 30, 2025 | 436.76M |
| March 31, 2025 | 418.62M |
| December 31, 2024 | 403.68M |
| September 30, 2024 | 405.95M |
| June 30, 2024 | 455.76M |
| March 31, 2024 | 451.96M |
| December 31, 2023 | 432.75M |
| September 30, 2023 | 429.86M |
| June 30, 2023 | 434.47M |
| March 31, 2023 | 339.48M |
| December 31, 2022 | 338.54M |
| September 30, 2022 | 336.68M |
| June 30, 2022 | 336.96M |
| March 31, 2022 | 346.09M |
| December 31, 2021 | 358.74M |
| September 30, 2021 | 191.40M |
| June 30, 2021 | 191.92M |
| March 31, 2021 | 203.71M |
| December 31, 2020 | 195.70M |
| September 30, 2020 | 195.10M |
| June 30, 2020 | 191.34M |
| Date | Value |
|---|---|
| March 31, 2020 | 201.17M |
| December 31, 2019 | 212.79M |
| September 30, 2019 | 213.13M |
| June 30, 2019 | 207.66M |
| March 31, 2019 | 199.71M |
| December 31, 2018 | 197.26M |
| September 30, 2018 | 192.46M |
| June 30, 2018 | 185.11M |
| March 31, 2018 | 179.64M |
| December 31, 2017 | 174.76M |
| September 30, 2017 | 182.80M |
| June 30, 2017 | 176.55M |
| March 31, 2017 | 172.21M |
| December 31, 2016 | 169.65M |
| September 30, 2016 | 168.83M |
| June 30, 2016 | 163.78M |
| March 31, 2016 | 160.18M |
| December 31, 2015 | 160.08M |
| September 30, 2015 | 155.89M |
| June 30, 2015 | 149.50M |
| March 31, 2015 | 144.74M |
| December 31, 2014 | 139.78M |
| September 30, 2014 | 99.49M |
| June 30, 2014 | 91.60M |
| March 31, 2014 | 92.09M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viatris, Inc. | 14.26B |
| Liquidia Corp. | 195.11M |
| Elanco Animal Health, Inc. | 6.588B |
| Harmony Biosciences Holdings, Inc. | 999.24M |
| Corcept Therapeutics, Inc. | 705.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.494B |
| Total Liabilities (Quarterly) | 896.90M |
| Debt to Equity Ratio | 1.022 |
| Current Ratio | 2.909 |
| Net Debt Paydown Yield | 0.39% |